COMMUNIQUÉS West-GlobeNewswire

DBV Technologies publie sa position de trésorerie au 31 décembre 2017
20/02/2018
Communiqué de Presse Montrouge, France, le 20 février 2018 (7h30 CET) DBV Technologies publie sa position de trésorerie au 31 décembre 2017 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), [...]
CLINUVEL unveils new global positioning
20/02/2018
MELBOURNE, Australia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (XETRA-DAX:UR9) (NASDAQ INTERNATIONAL DESIGNATION ADR:CLVLY) today released its new global Company positioning including the [...]
Adamas Announces Declaratory Judgment Action Filed by Osmotica Related to Approved OSMOLEX ER
20/02/2018
EMERYVILLE, Calif., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) announced today that it has learned that Osmotica Pharmaceuticals LLC and Vertical Pharmaceuticals LCC (Osmotica) filed [...]
Burcon Announces Details of Completed Rights Offering
19/02/2018
VANCOUVER, British Columbia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon ") is pleased to announce that, further to its press release dated February 14, 2018 [...]
FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER™ (amantadine) extended-release tablets for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions in Adults
19/02/2018
BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) [...]
BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at Two Upcoming Healthcare Investor Conferences
19/02/2018
RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., Feb. 19, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), today announced they will be presenting at [...]
Sanofi: Disclosure of trading in own shares
19/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/5f7e1210-1c87-4466-91ad-c83329e827dd
Sanofi : Déclaration des transactions sur actions propres
19/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/41c2db5d-2733-40d9-9be1-05b72b1bafd8
Ossur Hf : Transactions in relation to share buyback program
19/02/2018
Announcement from Össur hf. No. 11/2018 Reykjavík, 19 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Transactions under Novozymes’ stock buyback program
19/02/2018
Please read the full announcement in the attached PDF http://prlibrary-eu.nasdaq.com/Resource/Download/fe173723-e6ca-4eb1-9177-48696a6c841e
Notice to convene annual general meeting 2018 of GN Store Nord
19/02/2018
Please find enclosed notice of GN Store Nord A/S’ annual general meeting 2018, including the complete proposals for the agenda. For further information, please contact: Investors and analysts Peter Justesen VP – [...]
The American Health Council Names Gilberto Alvarado, MSN, CNP, FNP-BC, BSN, RN to Board of Nurses
19/02/2018
NEW YORK, Feb. 19, 2018 (GLOBE NEWSWIRE) -- Gilberto “Gil” Alvarado, MSN, CNP, FNP-BC, BSN, RN is named to the American Health Council’s Board of Nurses for his impeccable contributions to the nursing field, both in a [...]
Alder BioPharmaceuticals® to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial and Operating Results
19/02/2018
BOTHELL, Wash., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
19/02/2018
FIT Biotech Oy Company release February 19, 2018 at 2:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Novo Nordisk A/S - Share repurchase programme
19/02/2018
Bagsværd, Denmark, 19 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Notice of Annual General Meeting
19/02/2018
Valby, Denmark, 2018-02-19 09:04 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 19 February 2018 – Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Tuesday, 20 March 2018 at 10:00 am The [...]
Oasmia Pharmaceutical’s Docecal program achieves significant development milestone
19/02/2018
Oasmia Pharmaceutical AB announces that all patients have been treated in the two ongoing studies with Docecal in metastatic breast cancer. Uppsala, Sweden, February 19, 2018 – Oasmia Pharmaceutical AB (NASDAQ: OASM), a [...]
Bone Therapeutics SA completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB®
19/02/2018
Press release Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB ® Efficacy and safety results expected in mid-2019 Promising interim efficacy and safety data already reported [...]
Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB®
19/02/2018
Communiqué de presse Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB ® Résultats d'efficacité et de sécurité attendus mi-2019 Données [...]

Pages